EUVIMEDEUVIMED entdecken
Crossref

Amniotic bladder therapy: study of micronized amnion/chorion for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) at 6 months

Kyle O'Hollaren, Jack Considine, Codrut Radoiu, Raghav Madan, Aron Liaw, Nivedita Dhar

International Urology and Nephrology · 2024

DOI: 10.1007/s11255-024-04251-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Kyle O'Hollaren und 5 weiteren Autor:innen. Beteiligte Einrichtung: Wayne State University School of Medicine, Detroit, MI, USA. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Amnion. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intravesical application of birth tissue has been reported to inhibit inflammation, alleviate collagen fiber accumulation, and enhance bladder tissue generation. We have previously reported that intra-detrusor micronized amnion monolayer (AM) injections provide short-term clinical improvement in refractory IC/BPS patients. Herein, we evaluate the therapeutic responses and adverse events of micronized amnion/chorion bilayer (AC) in patients with refractory IC/BPS with 6 months follow-up. METHODS: Fifteen patients affected by IC/BPS who failed conventional therapy received 100 mg of reconstituted micronized AC was injected intra-detrusor via cystoscopy under general anesthesia, using a 23-gauge needle. Twenty 0.5-mL injections were administered into the lateral and posterior bladder walls, avoiding the dome and trigone. Changes in interstitial cystitis symptom index (ICSI), Interstitial cystitis problem index (ICPI), Bladder pain/ interstitial cystitis symptom score (BPIC-SS) and Overactive Bladder Assessment Tool (OAB), from baseline to 6 months post-injection were evaluated retrospectively. The safety of injections was analyzed. RESULTS: Fifteen total refractory IC/BPS patients with an average age of 41.1 ± 14.5 years were included in the study, receiving intra-detrusor injections of 100 mg of micronized AC. One month after injections, significant improvement in IC/BPS symptom scores was noted in all patients. All patients maintained a sustained clinical response at 6 months post-injection. No product-related adverse events were observed. CONCLUSION: Our findings indicate that the AC formulation significantly reduces time to symptom relief in patients with refractory interstitial cystitis/bladder pain syndrome (IC/BPS) and maintains a sustained response up to 6 months post-injection. These results suggest a promising clinical benefit of using an amnion/chorion bilayer product for treating IC/BPS. Further research is needed to confirm these findings and assess the long-term durability of this treatment approach. This study represents the first evidence supporting the clinical advantages of an amnion/chorion bilayer product in managing IC/BPS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystitis, InterstitialAmnionHumansFemaleAdultMiddle AgedMaleRetrospective StudiesTime FactorsTreatment OutcomeAdministration, IntravesicalFollow-Up Studies

Stichwörter der Autor:innen

AmnioticBladder pain syndromeInterstitial cystitisIntravesical therapyLower urinary tract symptomsPainful bladder syndrome

Autor:innen und Institutionen

  • Wayne State University School of Medicine, Detroit, MI, USA.
  • John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI, 48201, USA.
  • John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI, 48201, USA. Ec0362@wayne.edu.
  • Detroit Medical Center, Detroit, MI, USA. Ec0362@wayne.edu.

Zitieren

APA

O'Hollaren, K., Considine, J., Radoiu, C., Madan, R., Liaw, A., & Dhar, N. (2024). Amniotic bladder therapy: study of micronized amnion/chorion for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) at 6 months. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-04251-x

Vancouver

O'Hollaren K, Considine J, Radoiu C, Madan R, Liaw A, Dhar N. Amniotic bladder therapy: study of micronized amnion/chorion for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) at 6 months. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-04251-x

BibTeX
@article{OHollaren2024,
  author = {O'Hollaren, Kyle and Considine, Jack and Radoiu, Codrut and Madan, Raghav and Liaw, Aron and Dhar, Nivedita},
  title = {Amniotic bladder therapy: study of micronized amnion/chorion for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) at 6 months},
  journal = {International Urology and Nephrology},
  year = {2024},
  doi = {10.1007/s11255-024-04251-x}
}
Kostenlos starten →